Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer [Yahoo! Finance]
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Fortress Biotech, Inc. (NASDAQ: FBIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights